Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Biological Sciences|January 22, 2019
Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT PathwayFengkai Xu, Jie Gu, Chunlai Lu, et al.
Communications Biology|May 29, 2023
KLF11 regulates lung adenocarcinoma ferroptosis and chemosensitivity by suppressing GPX4Guangyin Zhao, Jiaqi Liang, Guangyao Shan, et al.
BMC Cancer|September 5, 2019
TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinomaFengkai Xu, Shu Zhang, Zhonghe Liu, et al.
ACS Applied Materials & Interfaces|January 20, 2026
Synergistic Lattice-Strain and Electronic Modulation in Cobalt Oxide for Enhanced Proton Exchange Membrane Water ElectrolysisZhi Wang, Zhiming Bai, Chengdeng Wang, et al.
Molecular Cancer Research : MCR|October 1, 2024
Gram-Negative Microflora Dysbiosis Facilitates Tumor Progression and Immune Evasion by Activating the CCL3/CCL5-CCR1-MAPK-PD-L1 Pathway in Esophageal Squamous Cell CarcinomaHuiqin Yang, Jiahao Cai, Xiaolong Huang, et al.
BMC Pulmonary Medicine|May 26, 2022
An individual nomogram can reliably predict tumor spread through air spaces in non-small-cell lung cancerShuai Wang, Huankai Shou, Haoyu Wen, et al.
Cancer Letters|December 4, 2018
Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complexJie Gu, Wei Mao, Wenjia Ren, et al.
Hepatology (Baltimore, Md.)|July 25, 2015
B cells expressing CD11b effectively inhibit CD4+ T-cell responses and ameliorate experimental autoimmune hepatitis in miceXiaoming Liu, Xuechao Jiang, Ronghua Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2014
DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signalingRonghua Liu, Jie Gu, Pei Jiang, et al.
Cancer Immunology, Immunotherapy : CII|March 12, 2022
Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancerHongyu Zhang, Zilong Liu, Haoyu Wen, et al.
Pageof 4